Gainers
Senseonics Holdings, Inc. (NYSE: SENS) rose 37.1% to $2.81 in pre-market trading after the company disclosed results from a PROMISE study evaluating its Eversense CGM System for up to 180 days. The Eversense CGM is a continuous glucose monitoring device.
Gainers
Five Below (NASDAQ: FIVE) shares are trading higher after the company reported better-than-expected Q1 EPS and sales results and issued Q2 EPS and sales guidance above estimates.